{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:53:27Z","timestamp":1786467207185,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.colsurfb.2026.115955","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:38:29Z","timestamp":1782851909000},"page":"115955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nose-to-brain delivery of riluzole-loaded nanoemulsion in a controlled cortical impact-induced traumatic brain injury: Insights from In vitro, Ex vivo, and In vivo studies"],"prefix":"10.1016","volume":"267","author":[{"given":"Etikala","family":"Amulya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P.","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4363","authenticated-orcid":false,"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.115955_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122941","article-title":"Implantation of MSC spheroid-derived 3D decellularized ECM enriched with the MSC secretome ameliorates traumatic brain injury and promotes brain repair","volume":"315","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.115955_bib2","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s10787-025-01923-7","article-title":"Unlocking therapeutic potential in traumatic brain injury: exploring microenvironmental targets, signaling pathways and translational hurdles","volume":"33","author":"Bahuguna","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.colsurfb.2026.115955_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuint.2005.12.001","article-title":"Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury","volume":"48","author":"Yi","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.colsurfb.2026.115955_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HTR.0000000000000537","article-title":"Pharmacotherapy for treatment of cognitive and neuropsychiatric symptoms after mTBI","volume":"35","author":"Rabinowitz","year":"2020","journal-title":"J. Head. Trauma. Rehabil."},{"key":"10.1016\/j.colsurfb.2026.115955_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nmt-2020-0033","article-title":"Riluzole for the treatment of amyotrophic lateral sclerosis","volume":"10","author":"Saitoh","year":"2020","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.colsurfb.2026.115955_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2022.100052","article-title":"The effect of Riluzole on neurological outcomes, blood-brain barrier, brain water and neuroinflammation in traumatic brain injury","volume":"8","author":"nikbakht","year":"2022","journal-title":"Brain Disord."},{"key":"10.1016\/j.colsurfb.2026.115955_bib7","article-title":"The effect of Riluzole on neurological outcomes, blood-brain barrier, brain water and neuroinflammation in traumatic brain injury","volume":"8","author":"Siahposht-khachaki","year":"2022","journal-title":"Brain Disord."},{"key":"10.1016\/j.colsurfb.2026.115955_bib8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/neu.1996.13.767","article-title":"Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat","volume":"13","author":"McIntosh","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.colsurfb.2026.115955_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuint.2011.10.017","article-title":"Riluzole elevates GLT-1 activity and levels in striatal astrocytes","volume":"60","author":"Carbone","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.colsurfb.2026.115955_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2007.04772.x","article-title":"Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier","volume":"103","author":"Milane","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.colsurfb.2026.115955_bib11","article-title":"Lipid engineered nanomaterials: a novel paradigm shift for combating stroke","volume":"38","author":"Amulya","year":"2024","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.colsurfb.2026.115955_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib13","article-title":"The nose has it: opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters","volume":"21","author":"Chung","year":"2023","journal-title":"Epilepsy Behav. Rep."},{"key":"10.1016\/j.colsurfb.2026.115955_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: in vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib15","article-title":"Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs","volume":"2023","author":"Preeti","year":"2023","journal-title":"Sci. (Cairo)"},{"key":"10.1016\/j.colsurfb.2026.115955_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/03639045.2020.1730396","article-title":"Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress","volume":"46","author":"Nabi","year":"2020","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125195","article-title":"Brain distribution study of [14C]-Riluzole following intranasal administration in mice","volume":"670","author":"Baker","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib18","first-page":"1130","article-title":"Nanoemulsions for intranasal delivery of riluzole to improve brain bioavailability: formulation development and pharmacokinetic studies","author":"Parikh","year":"2018","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.colsurfb.2026.115955_bib19","article-title":"High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for the management of atopic dermatitis","author":"Nene","year":"2024","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.colsurfb.2026.115955_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061246","article-title":"Design of topical moxifloxacin mucoadhesive nanoemulsion for the management of ocular bacterial infections","volume":"14","author":"Youssef","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2026.115955_bib21","doi-asserted-by":"crossref","first-page":"23952","DOI":"10.1039\/D4RA04624B","article-title":"A novel mucoadhesive paliperidone-nanoemulsion developed using the ultrasonication method in the treatment of schizophrenia","volume":"14","author":"Ahmad","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2026.115955_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121050","article-title":"Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies","volume":"607","author":"Gadhave","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106229","article-title":"Mucoadhesive meloxicam-loaded nanoemulsions: development, characterization and nasal applicability studies","volume":"175","author":"Sipos","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2026.115955_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124376","article-title":"Therapeutic potential of limonene-based syringic acid nanoemulsion: enhanced ex-vivo cutaneous deposition and clinical anti-psoriatic efficacy","volume":"660","author":"Assalem","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2018.03.055","article-title":"Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro","volume":"543","author":"Colombo","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121683","article-title":"Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson\u2019s disease","volume":"618","author":"Usama Ashhar","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115955_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127724","article-title":"Antioxidant and enzyme-inhibitory activity of peppermint extracts and essential oils obtained by conventional and emerging extraction techniques","volume":"338","author":"Pavli\u0107","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.colsurfb.2026.115955_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejphar.2013.09.023","article-title":"The neuroprotective effects of ipriflavone against H2O 2 and amyloid beta induced toxicity in human neuroblastoma SH-SY5Y cells","volume":"721","author":"Xiao","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2015.04.019","article-title":"Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model","volume":"160","author":"Patel","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ijbiomac.2018.06.190","article-title":"In vitro neuroprotective effects of naringenin nanoemulsion against \u03b2-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation","volume":"118","author":"Md","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2026.214835","article-title":"Nose-to-brain delivery of berberine-loaded nanoemulsion: amelioration of brain targeting, behavioral, pharmacokinetic, and biodistribution insights for Alzheimer\u2019s intervention","volume":"184","author":"Negi","year":"2026","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.colsurfb.2026.115955_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuro.2009.02.014","article-title":"Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurones of rats: behavioural and electrophysiological evidence","volume":"30","author":"Janahmadi","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.colsurfb.2026.115955_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110077","article-title":"Riluzole ameliorates soluble A\u03b21\u201342-induced impairments in spatial memory by modulating the glutamatergic\/GABAergic balance in the dentate gyrus","volume":"108","author":"Yang","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.colsurfb.2026.115955_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbr.2017.03.035","article-title":"Administration of riluzole into the basolateral amygdala has an anxiolytic-like effect and enhances recognition memory in the rat","volume":"327","author":"Sugiyama","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.colsurfb.2026.115955_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2012.03.089","article-title":"Attenuation of interleukin-1beta by pulsed electromagnetic fields after traumatic brain injury","volume":"519","author":"Rasouli","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.colsurfb.2026.115955_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178593","article-title":"Neuroinflammatory signature of post-traumatic confusional state: the role of cytokines in moderate-to-severe traumatic brain injury","volume":"26","author":"Piancone","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115955_bib37","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s12035-021-02293-1","article-title":"Infliximab can improve traumatic brain injury by suppressing the tumor necrosis factor alpha pathway","volume":"58","author":"Zhou","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib38","article-title":"Edaravone attenuates traumatic brain injury through anti\u2011inflammatory and anti\u2011oxidative modulation","author":"Zhang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.colsurfb.2026.115955_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2026.102632","article-title":"Riluzole in neuroinflammation and neurodegeneration: mechanistic insights and experimental validation","volume":"88","author":"Abd-Eldayem","year":"2026","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib40","doi-asserted-by":"crossref","first-page":"19716","DOI":"10.1021\/acsami.6b01776","article-title":"Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle","volume":"8","author":"Verma","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.115955_bib41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8","article-title":"Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat","volume":"52","author":"Zhang","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.colsurfb.2026.115955_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-8993(97)00144-3","article-title":"Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury","volume":"756","author":"Wahl","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.colsurfb.2026.115955_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/neu.2000.17.1171","article-title":"Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury","volume":"17","author":"Stover","year":"2000","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.colsurfb.2026.115955_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/neu.1996.13.767","article-title":"Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat","volume":"13","author":"McIntosh","year":"1996","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.colsurfb.2026.115955_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/neu.1997.14.839","article-title":"Time course of cerebral edema after traumatic brain injury in rats: effects of riluzole and mannitol","volume":"14","author":"Bareyre","year":"1997","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.colsurfb.2026.115955_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-026-05182-3","article-title":"Intranasal co-delivery of riluzole and berberine via chitosan-coated PLGA nanoparticles for synergistic neuroprotection in Alzheimer\u2019s disease: formulation, characterization, and pharmacokinetics analysis","author":"komy","year":"2026","journal-title":"Naunyn. Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/01932691.2025.2532540","article-title":"Nose to brain delivery of thermosensitive hydrogel system containing riluzole nanosuspension: design, physicochemical characterization and antidepressant efficacy","author":"Taymouri","year":"2025","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.115955_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.122749","article-title":"Riluzole-loaded lipid nanoparticles for brain Delivery: preparation, optimization and characterization","volume":"388","author":"In\u00eas Teixeira","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.colsurfb.2026.115955_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution","volume":"5","author":"Bond\u00ec","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2026.115955_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010185","article-title":"Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain","volume":"14","author":"Teixeira","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526005436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526005436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:11:42Z","timestamp":1786464702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526005436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0927776526005436"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115955","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of riluzole-loaded nanoemulsion in a controlled cortical impact-induced traumatic brain injury: Insights from In vitro, Ex vivo, and In vivo studies","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115955"}}